Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers Squibb Company: Today's Featured Health Care Winner
The Street
Saturday, May 11, 2013 - 11:40am
tags:
Bristol-Myers Squibb
Boston Scientific’s Mahoney Says Watchman Key to Growth
Bloomberg
Saturday, May 11, 2013 - 11:39am
tags:
Boston Scientific, WATCHMAN, atrial fibrillation, devices
Breo Ellipta gains US approval for the treatment of COPD
Yahoo/PR Newswire
Saturday, May 11, 2013 - 11:20am
tags:
Breo Ellipta, COPD, GSK, Theravance
Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Ventrus Biosciences, Inc.
Yahoo/PR Newswire
Saturday, May 11, 2013 - 11:18am
tags:
Ventrus, lawsuits
3 Big Pharma Stocks With Lower Credit Risk Than U.S. Treasuries: Part I
Motley Fool
Saturday, May 11, 2013 - 11:17am
tags:
Bristol-Myers Squibb, Eli Lilly, JNJ
No Fat in This Drug Launch
Motley Fool
Saturday, May 11, 2013 - 11:16am
tags:
Amarin, Vascepa, dyslipidemia
J&J: Before We Hand Over That $2.2 Billion . . .
Yahoo/YCharts
Saturday, May 11, 2013 - 11:14am
tags:
JNJ, lawsuits, legal
Why Does Arena's Obesity Drug Have Abuse Potential?
Forbes
Saturday, May 11, 2013 - 11:12am
tags:
Arena Pharmaceuticals, Belviq, weight loss, obesity
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, May 11, 2013 - 11:10am
tags:
Xoma, WebMD, Sequenom
Discovery Labs to Float Stock Issue
Motley Fool
Saturday, May 11, 2013 - 11:09am
tags:
Discovery Labs
BioTime Announces First Quarter 2013 Financial Results and Recent Corporate Accomplishments
Yahoo/BusinessWire
Saturday, May 11, 2013 - 11:08am
tags:
BioTime, earnings
Nektar Therapeutics Increases Sales but Misses Estimates on Earnings
Motley Fool
Saturday, May 11, 2013 - 11:08am
tags:
Nektar, earnings
Medivation Inc.: Today's Featured Drugs Laggard
The Street
Saturday, May 11, 2013 - 11:07am
tags:
Medivation
Cramer: Biotech Makes a Comeback
The Street
Saturday, May 11, 2013 - 11:05am
tags:
Actavis Said to Be in Early Talks to Acquire Warner Chilcott
Bloomberg
Friday, May 10, 2013 - 1:42pm
tags:
Actavis, Warner Chilcott, M&A
Progenics 1Q loss narrows, revenue tops Street
Yahoo/AP
Friday, May 10, 2013 - 1:40pm
tags:
Progenics, earnings
Achillion: Down But Not Out And Progress Being Made
Seeking Alpha
Friday, May 10, 2013 - 1:39pm
tags:
Achillion, Bristol-Myers Squibb
Analysis: Drugmakers face more scrutiny of discordant U.S. prices
Yahoo/Reuters
Friday, May 10, 2013 - 12:49pm
tags:
drug pricing
Dendreon Earnings Show Poor Provenge Sales, Implosion Risk Rising
24/7 Wall St.
Friday, May 10, 2013 - 12:47pm
tags:
Dendreon, earnings
Pain Therapeutics discloses Pfizer reassessing continued Remoxy partnership
The Fly on the Wall
Friday, May 10, 2013 - 12:45pm
tags:
Pain Therapeutics, Remoxy, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.